Detection of lymphoma in bone marrow by whole-body positron emission tomography

Blood

Volumn 91, Issue 9, 1998, Pages 3340-3346

  Carr, Robert ^a,b   Barrington, Sally F ^a   Madan, Bella ^a   O'Doherty, Michael J ^a   Saunders, Catherine A B ^a   Van Der Walt, Jon ^a   Timothy, Adrian R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CANCER GRADING; DIAGNOSTIC IMAGING; GLYCOLYSIS; HUMAN; HUMAN CELL; LYMPH NODE BIOPSY; LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY AUTORADIOGRAPHY;

EID: 0032080192     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3340.3340_3340_3346     Document Type: Article

References (33)

1. McKenna RW: The bone marrow manifestations of Hodgkin's disease, the non-Hodgkin lymphomas, and lymphoma-like disorders, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 1135
2. Macintyre EA, Vaughan-Hudson B, Linch DC, Vaughan-Hudson G, Jelliffe AM: The value of staging bone marrow trephine biopsy in Hodgkin's disease. Eur J Haematol 39:66, 1987
3. Pond GD, Castellino RA, Horning S, Hoppe RT: Non-Hodgkin's lymphoma: Influence of lymphography, CT and bone marrow biopsy on staging and management. Radiology 170:159, 1989
4. Howard MR, Taylor PRA, Lucraft HH, Taylor MJ, Proctor SJ: Bone marrow examination in newly diagnosed Hodgkin's disease: Current practice in the United Kingdom. Br J Cancer 71:210, 1995
5. Brunning RD, Bloomfield CD, McKenna RW, Peterson L: Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic disease. Ann Intern Med 82:365, 1975
6. Ebie N, Loew JM, Gregory SA: Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma: A second look. Hematol Pathol 3:29, 1989
7. Haddy TB, Parker RI, Magrath IT: Bone marrow involvement in young patients with non-Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 17:418, 1989
8. Juneja SK, Wolf MM, Cooper IA: Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 43:630, 1990
9. Warburg O: On the origin of cancer cells. Science 123:309, 1956
10. Wahl RL: Targeting glucose transporters for tumor imaging: "sweet" idea "sour" result. J Nucl Med 37:1038, 1996
11. Hawkins RA, Hoh C, Glaspy J, Rege S, Choi Y, Phleps ME: Positron emission tomography scanning in cancer. Cancer Invest 12:74, 1994
12. Barrington SF, Carr R: Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning. Clin Oncol 7:334, 1995
13. Ichiya Y, Kuwabara Y, Otsuda M, Tahara T, Yoshikai T, Fukumura T, Jingu K, Masuda K: Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 32:1655, 1991
14. Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, Kuyama J, Maruno H, Arimizu N: The use of FDG-PET in the detection and management of malignant lymphoma: Correlation of uptake with prognosis. J Nucl Med 32:686, 1991
15. Okada J, Yoshikawa K, Itami M, Imaseki K, Uno K, Itami J, Kuyama J, Mikata A, Arimizu N: Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: A comparison of proliferative activity. J Nucl Med 33:325, 1992
16. Newman JS, Francis IR, Kaminski MS, Wahl RL: Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: Correlation with CT. Radiology 190:111, 1994
17. Hoh CK, Glaspy J, Rosen P, Dahlbom M, Lee SJ, Kunkel L, Hawkin RA, Maddahi J, Phelps ME: Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38:343, 1997
18. Stroobans S, Dupont P, Verhoef G, Thomas J, Vleugels S, Bormans G, De Roo M, Boogaerts M, Morrtelmans L: Comparison of whole-body positron emission tomography and gallium-67 citrate imaging for staging of lymphoma. Blood 88:228a, 1996 (abstr, suppl 1)
19. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
20. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33:159, 1977
21. Weisenburger DD, Armitage JO: Mantle cell lymphoma - An entity comes of age. Blood 87:4483, 1996
22. Neilson JR, Fegan CD, Milligan DW: Mantle cell leukaemia? Br J Haematol 93:494, 1996 (letter)
23. Paul R: Comparison of fluorine-18-2-fluoroodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 28:288, 1987
24. Leskinen-Kallio S, Ruotsalainen U, Någren K, Teräs M, Joensuu H: Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: A PET study. J Nucl Med 32:1211, 1991
25. Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH: Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: Potential role in oncologic imaging. RadioGraphics 13:1047, 1993
26. Lapela M, Leskinen S, Minn HRI, Lindholm P, Klemi PJ, Söderström K-O, Bergman J, Haaparanta M, Ruotsalainen U, Solin O, Joensuu H: Increased glucose metabolism in untreated non-Hodgkin's lymphoma: A study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 86:3522, 1995
27. Rodriguez M, Rehn S, Ahlstrom H, Sundström C, Glimelius B: Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J Nuci Med 36:1790, 1995
28. Hoane BR, Shields AF, Porter BA, Borrow JW: Comparison of initial lymphoma staging using computed tomography (CT) and magnetic resonance (MR) imaging. Am J Hematol 47:100, 1994
29. Musemeci R, Tesoro-Tess JD: New imaging techniques in staging lymphomas. Curr Opin Oncol 6:464, 1994
30. Linden A, Zankovich R, Theissen P, Diehl V, Schicha H: Malignant lymphoma: Bone marrow imaging versus biopsy. Radiology 173:335, 1989
31. Chung JK, Yeo J, Lee DS, Park S, Lee MC, Kim BK, Koh CS: Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders. J Nucl Med 37:978, 1996
32. Reske S, Kartsens J, Sohn M, Glöckner W, Buell U: Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases. Acta Oncol 32:753, 1993
33. Meikle SR, Bailey DL, Hooper PK, Eberl S, Hutton BF, Jones WF, Fulton RR, Fulham MJ: Simultaneous emission and transmission measurements for attenuation correction in whole body PET. J Nucl Med 36:1680, 1995